ctl immunospot analyzer (Cellular Technology Ltd)
99
Structured Review
Cellular Technology Ltd
ctl immunospot analyzer
Ctl Immunospot Analyzer, supplied by Cellular Technology Ltd, used in various techniques. Bioz Stars score: 99/100, based on 2096 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ctl+immunospot+analyzer/ImmunoSpot+Software/bio_rxiv__64898__2026__03__13__711721-67-48-48
Average 99 stars, based on 2096 article reviews
Ctl Immunospot Analyzer, supplied by Cellular Technology Ltd, used in various techniques. Bioz Stars score: 99/100, based on 2096 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ctl+immunospot+analyzer/ImmunoSpot+Software/bio_rxiv__64898__2026__03__13__711721-67-48-48
Average 99 stars, based on 2096 article reviews
ctl immunospot analyzer - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Software:Article Title: Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade. Article Snippet: After incubation for 22 h at 37 °C in a CO2 incubator, the plate was developed using 0.2 μg ml−1 biotinylated anti-human IFNγ monoclonal antibody (Mabtech, 7-B6-1), 1 μg ml−1 streptavidin-alkaline phosphatase conjugate (Roche Diagnostics) and 5-bromo-4-chloro-3-indolyl phosphate/NBT (Sigma-Aldrich). .. The number of spots was evaluated using a Article Title: Methods and compositions comprising cationic lipids for stimulating type 1 interferon genes Article Snippet: .. Spots were scanned and counted using Article Title: Breadth of antibody activity elicited by an influenza B hemagglutinin vaccine is influenced by pre-existing immune responses to influenza B viruses. Article Snippet: .. Plates were allowed to dry at RT in the dark for 2 days and then scanned and counted using a Article Title: Antigen cross-presentation potentiating cancer vaccine adjuvant for T cell expansion and synergy with anti-PD-1 Article Snippet: The spots were developed using an AEC substrate set (551951, BD Bioscience, USA). .. IFN-γ-producing cells were analyzed using a Article Title: Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade Article Snippet: After incubation for 22 h at 37 °C in a CO 2 incubator, the plate was developed using 0.2 μg ml −1 biotinylated anti-human IFNγ monoclonal antibody (Mabtech, 7-B6-1), 1 μg ml −1 streptavidin-alkaline phosphatase conjugate (Roche Diagnostics) and 5-bromo-4-chloro-3-indolyl phosphate/NBT (Sigma-Aldrich). .. The number of spots was evaluated using a Virus:Article Title: Efficacy and safety of a novel multivalent mRNA vaccine against SARS-CoV-2 in experimental animals. Article Snippet: .. The number of blue virus foci was measured using a Enzyme-linked Immunospot:Article Title: HEPLISAV-B Breaks Immune Tolerance and Induces HBV Control via CD4 T Cell-Dependent Mechanisms in a Chronic Hepatitis B Mouse Model Article Snippet: IFN-γ–producing cells were assessed after 48 h stimulation with HBsAg (20 μg/mL) in the presence of CD28/CD49d co-stimulatory antibodies (BD Biosciences, #347690); CD3/CD28 microbeads served as positive controls. .. For total and HBsAg-specific IgG detection, splenocytes were pre-stimulated with mouse B-Poly-STM reagent for 5 days, then transferred to pre-activated ELISPOT plates coated with Igκ/λ or HBsAg (10 μg/mL) and incubated for 16 h. Assays were performed according to the manufacturer’s instructions, and plates were analyzed using a Incubation:Article Title: HEPLISAV-B Breaks Immune Tolerance and Induces HBV Control via CD4 T Cell-Dependent Mechanisms in a Chronic Hepatitis B Mouse Model Article Snippet: IFN-γ–producing cells were assessed after 48 h stimulation with HBsAg (20 μg/mL) in the presence of CD28/CD49d co-stimulatory antibodies (BD Biosciences, #347690); CD3/CD28 microbeads served as positive controls. .. For total and HBsAg-specific IgG detection, splenocytes were pre-stimulated with mouse B-Poly-STM reagent for 5 days, then transferred to pre-activated ELISPOT plates coated with Igκ/λ or HBsAg (10 μg/mL) and incubated for 16 h. Assays were performed according to the manufacturer’s instructions, and plates were analyzed using a Control:Article Title: HEPLISAV-B Breaks Immune Tolerance and Induces HBV Control via CD4 T Cell-Dependent Mechanisms in a Chronic Hepatitis B Mouse Model Article Snippet: IFN-γ–producing cells were assessed after 48 h stimulation with HBsAg (20 μg/mL) in the presence of CD28/CD49d co-stimulatory antibodies (BD Biosciences, #347690); CD3/CD28 microbeads served as positive controls. .. For total and HBsAg-specific IgG detection, splenocytes were pre-stimulated with mouse B-Poly-STM reagent for 5 days, then transferred to pre-activated ELISPOT plates coated with Igκ/λ or HBsAg (10 μg/mL) and incubated for 16 h. Assays were performed according to the manufacturer’s instructions, and plates were analyzed using a |